Page 207 - 2025中醫藥與天然藥物聯合學術研討會-中醫藥與天然藥物的挑戰X機遇與未來大會手冊
P. 207

PP-25


               Modeling  Wnt3A‑driven  liver  progenitor  cell  transformation  with  a

               co‑culture reporter system for drug screening


                                1,2
                                                 3,4
               Li-Xuan Huang,  Yi-Siao Chen,  Chia-Hung Yen*        ,2,3,4,5

               1  Department of Fragrance and Cosmetic Science, College of Pharmacy, Kaohsiung Medical
                 University, Kaohsiung, Taiwan
               2  Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical
                 University, Kaohsiung, Taiwan
               3  Ph.D. Program in Environmental and Occupational Medicine, College of Medicine,
                 Kaohsiung Medical University, Kaohsiung, Taiwan
               4  Drug Development and Value Creation Research Center, Kaohsiung Medical University,
                 Kaohsiung, Taiwan
               5  Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan
               * Email: chyen@kmu.edu.tw

               Abstract
                  Liver progenitor cells (LPCs) play a pivotal role in hepatic repair and regeneration under
               physiological conditions but may undergo dedifferentiation and malignant transformation into
               liver cancer stem cells (LCSCs) in chronic inflammation and fibrosis. This malignant transition
               is increasingly recognized as a key mechanism linking steatohepatitis to hepatocarcinogenesis.
               Although Wnt/β-catenin signaling has been implicated as a critical driver, its context-dependent
               mechanisms  in  LPCs  remain  insufficiently  characterized.  Moreover,  the  lack  of  an  LPC-
               centered screening platform has limited the exploration of natural products as multi-targeted
               and low-toxicity therapeutic candidates. Here, we developed and validated a co-culture–based
               reporter assay to investigate Wnt/β-catenin signaling in LPCs and enable systematic screening
               of natural inhibitors. A stable Wnt/β-catenin luciferase reporter LPC line (WB-F344/luc) was
               established and co-cultured with Wnt3a-secreting HEK293A cells. Wnt3a induced dose- and
               ratio-dependent  reporter  activation  in  the  co-culture  system,  which  remained  robust  and
               reproducible over ten days. Notably, LPCs co-cultured with a higher proportion of Wnt3a-
               secreting HEK293A cells were more sensitive to trypsin and exhibited reduced adhesion, such
               that even mild mechanical force could detach the cells. As proof of concept, the co-culture
               reporter system confirmed that the water extract of Gynura divaricata—which our prior studies
               revealed  to  attenuate  Wnt  signaling  and  CSC  characteristics  in  Huh7  hepatoma  cells—
               significantly suppressed Wnt3a-induced reporter activity, supporting its application in natural
               product–based drug discovery.    In conclusion, this LPC-centered co-culture platform provides
               a scalable and reproducible tool for high-throughput identification of Wnt/β-catenin modulators.
               With future prospects, this platform could be applied to long-term co-culture with hepatocytes,
               kupffer cells, and hepatic stellate cells to better recapitulate the hepatic microenvironment.
               Furthermore, it may be extended to the development of 3D multicellular organoid systems for
               more physiologically relevant liver disease modeling.

               Keywords:  Wnt/β-catenin  signaling;  Liver  progenitor  cells;  Liver  cancer  stem  cells;  LPCs
                           malignant transformation;    Liver organoid; Co-culture system
   202   203   204   205   206   207   208   209   210   211   212